What Vir Biotechnology (VIR)'s profit swing but earnings miss means for shareholders Simply Wall St 2d Simply Wall St 2d
Fibrobiologics granted European patent covering Gene Therapy for the regeneration of cartilage PR Newswire (Press Release) 5d PR Newswire (Press Release) 5d
Forlong biotechnology announces approval to initiate Phase I clinical trial of FL115 (il-15 superagonist) subcutaneous injection in Australia Business Wire (Press Release) 6d Business Wire (Press Release) 6d
STAT Plus: Study reveals new role for tau, a top target for Alzheimer’s drug development STAT 3d STAT 3d
Percheron Therapeutics appoints Michael Baker as CEO as HMBD-002 trial approaches Proactive Investors (Australia) 01:36
Second Pic/S GMP Certification | Mabwell Passes Brazilian GMP Inspection for Its Denosumab Injections PR Newswire (Press Release) 01:05
Shanghai Henlius Biotech (SEHK:2696) Advances Oncology Pipeline, Is It Still 64% Below Fair Value? Simply Wall St 00:38
Nus researchers brandish light beams for biotechnology breakthrough The Straits Times 22:05 Sun, 09 Aug
BioNTech (BNTX) Cuts 2026 Guidance On An Undervalued Story Or Fair Warning Simply Wall St 12:35 Sun, 09 Aug
Gland Pharma inks strategic Cdmo deal with global pharma firm, eyes $90-100 million annual revenue The Times of India 06:50 Sun, 09 Aug
Loss of LATS1 promotes immune evasion in colon cancer via yap/Tead-driven lactate metabolism reprogramming Nature.com 06:07 Sun, 09 Aug
Amgen (AMGN) Is Up 6.7% After EMA Backs Broader Repatha Use in High-Risk Patients – Has The Bull Case Changed? Simply Wall St 12:49 Sat, 08 Aug